Patient and Economic Burden of Presbyopia: A Systematic Literature Review

被引:35
|
作者
Berdahl, John [1 ]
Bala, Chandra [2 ]
Dhariwal, Mukesh [3 ]
Lemp-Hull, Jessie [4 ]
Thakker, Divyesh [5 ]
Jawla, Shantanu [5 ]
机构
[1] Vance Thompson Vis, Sioux Falls, SD USA
[2] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia
[3] Alcon Vis LLC, Global Hlth Econ & Outcomes Res, Ft Worth, TX 76134 USA
[4] Alcon Vis LLC, Clin Dev & Med Affairs, Ft Worth, TX 76134 USA
[5] Novartis Healthcare Pvt Ltd, Patient Access Serv, Hyderabad, Telangana, India
来源
CLINICAL OPHTHALMOLOGY | 2020年 / 14卷
关键词
presbyopia; burden of disease; quality of life; productivity loss; patient satisfaction; utilities; QUALITY-OF-LIFE; UNCORRECTED REFRACTIVE ERRORS; SPECTACLE CORRECTION COVERAGE; INDIA RAPID ASSESSMENT; VISUAL IMPAIRMENT; VISION IMPAIRMENT; ANDHRA-PRADESH; GLOBAL BURDEN; SOUTH-INDIA; PREVALENCE;
D O I
10.2147/OPTH.S269597
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: The objective of this systematic literature review (SLR) was to collate, report, and critique published evidence related to epidemiology and patient and economic burden of presbyopia. Patients and Methods: A systematic literature search was conducted in MEDLINE (R), Embase (R), and Cochrane Library databases from the time of inception through October 2018 using Cochrane methodology. Studies published in English language reporting on epidemiology and patient and economic burden of presbyopia were included. Results: Initial systematic literature search yielded 2,228 citations, of which 55 met the inclusion criteria (epidemiology, 44; patient burden, 14; economic burden, 1) and were included in this review. Globally, 1.09 billion people are estimated to be affected by presbyopia. The reported presbyopia prevalence varied across regions and by age groups, with the highest prevalence of 90% reported in the Latin America region in adults >= 35 years. Presbyopic patients report up to 22% decrease in quality-of-life (QoL) score, and up to 80% patients with uncorrected presbyopia report difficulty in performing near-vision related tasks. About 12% of presbyopes required help in performing routine activities, and these visual limitations reportedly induce distress and low self-esteem in presbyopia patients. Uncorrected presbyopia led to a 2-fold increased difficulty in near-vision-related tasks and a >8-fold increased difficulty in very demanding near-vision-related tasks. Further, uncorrected presbyopia leads to a decrement in patients' QoL, evident by the low utility values reported in the literature. Annual global productivity losses due to uncorrected and under-corrected presbyopia in working-age population (<50 years) were estimated at US$ 11 billion (0.016% of the global domestic product (GDP) in 2011, which increased to US$ 25.4 billion if all people aged <65 years were assumed to be productive. Conclusion: Uncorrected presbyopia affects patients' vision-related quality of life due to difficulty in performing near-vision-related tasks. In addition, un-/under-corrected presbyopia could lead to productivity losses in working-age adults.
引用
收藏
页码:3439 / 3450
页数:12
相关论文
共 50 条
  • [41] The economic burden of heart failure: findings from a systematic literature review
    Freeman, C. L.
    Giles, L.
    Field, P.
    Osei-Assibey, G.
    Sorstadius, E.
    Kartman, B.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 422 - 422
  • [42] The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature
    Enstone A.
    Greaney M.
    Povsic M.
    Wyn R.
    Penrod J.R.
    Yuan Y.
    [J]. PharmacoEconomics - Open, 2018, 2 (2) : 125 - 139
  • [43] The clinical and economic burden of varicella in the Middle East: a systematic literature review
    Al Kaabi, Nawal
    Al Olama, Fatma Mohd Ali Sultan
    Al Qaseer, Mamoun
    Al Ubaidani, Idris
    Dinleyici, Ener Cagri
    Hayajneh, Wail Ahmad
    Bizri, Abdul Rahman
    Loulou, Maysoon
    Ndao, Tidiane
    Wolfson, Lara J.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (01) : 21 - 32
  • [44] Systematic Literature Review of the Economic Burden and Cost of Illness in Patients with Myelofibrosis
    Tang, Derek
    Taneja, Ankush
    Rajora, Preety
    Patel, Renu
    [J]. BLOOD, 2019, 134
  • [45] ASSESSING THE HUMAN AND ECONOMIC BURDEN OF SHORT STATURE: A SYSTEMATIC LITERATURE REVIEW
    Lundkvist, J.
    Shohet, S.
    Cookson, C.
    Law, L.
    Ribeiro-Oliveira, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S733 - S733
  • [46] ECONOMIC BURDEN OF SLE IN NORDIC COUNTRIES - A SYSTEMATIC LITERATURE REVIEW (SLR)
    Sharma, M.
    Ansari, S.
    Takyar, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S72 - S72
  • [47] The economic burden of overactive bladder in the United States: A systematic literature review
    Powell, Lauren C.
    Szabo, Shelagh M.
    Walker, David
    Gooch, Katherine
    [J]. NEUROUROLOGY AND URODYNAMICS, 2018, 37 (04) : 1241 - 1249
  • [48] THE ECONOMIC BURDEN OF AGITATION IN ALZHEIMER'S DISEASE: A SYSTEMATIC LITERATURE REVIEW
    Anatchkova, M.
    Brooks, A.
    Swett, L.
    Harty, A.
    Duffy, R.
    Baker, R.
    Hammer-Helmich, L.
    Aigbogun, Sanon M.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A192 - A192
  • [49] Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era
    Hsieh, Ping-Hsuan
    Wu, Olivia
    Geue, Claudia
    McIntosh, Emma
    McInnes, Iain B.
    Siebert, Stefan
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (06) : 771 - 777
  • [50] ECONOMIC BURDEN OF ANKYLOSING SPONDYLITIS IN EUROPE. A SYSTEMATIC REVIEW OF THE LITERATURE
    Blanch, C.
    Comellas, M.
    Prada, C.
    Lizan, L.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A541 - A541